• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail

Search Publications



Starting Date

Ending Date

Order by

Entry Details

J Microbiol Methods 2013 Feb 15;92(2):226-30

A 7-plex microbead-based immunoassay for serotyping Shiga toxin-producing Escherichia coli.

Clotilde LM, Bernard C 4th, Salvador A, Lin A, Lauzon CR, Muldoon M, Xu Y, Lindpaintner K, Carter JM


Serotyping of Shiga toxin-producing Escherichia coli (STEC) has been contingent upon the availability of antisera. Here we describe a 7-plex microbead-based immunoassay to simultaneously serotype seven STEC (i.e., belonging to serogroups O26, O45, O103, O111, O121, O145, and O157) by the Luminex xMAP(R) technology. This technology presents many advantages: Its multiplexed format (up to 100 analytes) saves time, reagents, and test sample, and many regulatory agencies currently utilize this platform for other assays. In this study, a total of seventy-nine STEC strains belonging to the 7 different serogroups of interest were tested. These strains had been previously serotyped and their serogroup confirmed by PCR. Except for one strain belonging to the O111 serogroup, nearly all strains (i.e., 98.7%; 78/79) were correctly identified on the Bio-Plex 100 instrument in less than 4 h. This newly developed microbead-based immunoassay could be extended to include other STEC serogroups, virulence factors, and/or bacterial species.

Category: Journal Article
PubMed ID: #23228591 DOI: 10.1016/j.mimet.2012.11.023
Includes FDA Authors from Scientific Area(s): Regulatory Affairs
Entry Created: 2012-12-12 Entry Last Modified: 2013-04-01